AlphaQuest LLC grew its position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 417.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 23,520 shares of the company's stock after purchasing an additional 18,978 shares during the period. AlphaQuest LLC's holdings in Option Care Health were worth $546,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently made changes to their positions in OPCH. UMB Bank n.a. increased its position in Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock worth $27,000 after buying an additional 346 shares during the last quarter. Quarry LP increased its holdings in shares of Option Care Health by 327.7% during the 3rd quarter. Quarry LP now owns 3,430 shares of the company's stock valued at $107,000 after acquiring an additional 2,628 shares during the last quarter. Blue Trust Inc. raised its stake in shares of Option Care Health by 16.9% in the 4th quarter. Blue Trust Inc. now owns 4,703 shares of the company's stock valued at $109,000 after acquiring an additional 681 shares in the last quarter. Venturi Wealth Management LLC lifted its holdings in Option Care Health by 2,621.3% in the 4th quarter. Venturi Wealth Management LLC now owns 4,735 shares of the company's stock worth $110,000 after purchasing an additional 4,561 shares during the last quarter. Finally, KBC Group NV boosted its position in Option Care Health by 16.2% during the third quarter. KBC Group NV now owns 5,013 shares of the company's stock worth $157,000 after purchasing an additional 700 shares during the period. 98.05% of the stock is owned by hedge funds and other institutional investors.
Option Care Health Stock Performance
Shares of OPCH stock traded down $0.65 during mid-day trading on Thursday, reaching $32.24. The stock had a trading volume of 3,309,090 shares, compared to its average volume of 1,623,281. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $34.85. The firm has a market cap of $5.33 billion, a PE ratio of 27.09, a P/E/G ratio of 2.30 and a beta of 1.33. The firm's 50 day simple moving average is $30.63 and its 200 day simple moving average is $28.25. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77.
Wall Street Analyst Weigh In
A number of brokerages have recently weighed in on OPCH. UBS Group started coverage on shares of Option Care Health in a research note on Thursday, December 5th. They issued a "neutral" rating and a $26.00 price objective for the company. Jefferies Financial Group raised shares of Option Care Health from a "hold" rating to a "buy" rating and boosted their target price for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. Bank of America raised Option Care Health from a "neutral" rating to a "buy" rating and raised their price target for the company from $26.00 to $33.00 in a research report on Monday, January 13th. JPMorgan Chase & Co. lifted their price objective on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research note on Thursday, March 6th. Finally, JMP Securities restated a "market outperform" rating and set a $30.00 target price (down previously from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, Option Care Health currently has an average rating of "Moderate Buy" and a consensus target price of $33.00.
Read Our Latest Stock Analysis on OPCH
Insider Transactions at Option Care Health
In related news, insider Michael Bavaro sold 30,996 shares of the stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the transaction, the insider now owns 44,974 shares of the company's stock, valued at $1,495,835.24. This represents a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.64% of the stock is owned by insiders.
Option Care Health Company Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Read More
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
